nifurtimox (Lampit) Report issue

Small molecule Orphan Drug FDA Approved FDA Accelerated Approval FDA Priority Review FDA

Active Ingredient History

NOW
  • Now
Nifurtimox, sold under the brand name Lampit, is a medication used to treat Chagas disease and sleeping sickness. For sleeping sickness it is used together with eflornithine in nifurtimox-eflornithine combination treatment. In Chagas disease it is a second-line option to benznidazole. It is given by mouth.   Wikipedia

  • SMILES: CC1CS(=O)(=O)CCN1\N=C\c2oc(cc2)[N+](=O)[O-]
  • InChIKey: ARFHIAQFJWUCFH-IZZDOVSWSA-N
  • Mol. Mass: 287.3
  • ALogP: 0.64
  • ChEMBL Molecule:
More Chemistry
  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: No

Drug Pricing (per unit)

United States

$1.8714 - $2.9548
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

bay-2502 | bay-a2502 | bayer 2502 | bayer-2502 | dndi1613515 | lampit | nifurtimox

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue